The DEGs were significantly enriched in the PI3K-AKT signaling pathway (Count = 125, padj = 0.0049), endocytosis (Count = 91, padj = 0.049), regulation of actin cytoskeleton (Count = 90, padj = 0.0001), and proteoglycans in cancer (Count = 83, padj = 0.0009) in ZEA treated dGCs (Figure 3C). This evidence concerns the gene AKT1 and cancer.